Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
To determine if supplements of vitamin C, vitamin E, beta-carotene, and B-vitamins (a
combination of folic acid, vitamins B6 and B12) reduce risk of major cardiovascular events in
high risk women with a prior history of atherosclerotic cardiovascular disease. The trial is
a companion to the Women's Health Study (WHS), a primary prevention trial of vitamin E and
aspirin in a low risk population of women.
Phase:
Phase 2
Details
Lead Sponsor:
Brigham and Women's Hospital
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Antioxidants Beta Carotene Carotenoids Folic Acid Hydroxocobalamin Pyridoxal Pyridoxine Vitamin B 12 Vitamin B 6 Vitamin B Complex Vitamin E Vitamins